Atlas Trials

A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants

Clinical trial NCT04476303 · COMPLETED

Trial details

NCT number
NCT04476303
Sponsor
BeyondBio Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2020-08-27
Primary completion
2021-11-23
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.